Header Logo

Connection

David Givand to Immunotherapy, Adoptive

Back to Details
This is a "connection" page, showing publications David Givand has written about Immunotherapy, Adoptive.
David Givand
Connection Strength
0.036
Immunotherapy, Adoptive
  1. Directing fratricide within T cell products using an anti-uPAR chimeric antigen receptor to drive the production of potent therapeutic cells. Mol Ther. 2026 Sep 02; 34(9):5190-5206.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.